In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P(450) enzyme identification, inhibition, and induction studies - Li, Y; Zhou, D; Ferguson, S S; Dorff, P; Simpson, T R; Grimm, S W (Xenobiotica, 2010)